Informed Consent
Item
written informed consent was provided
boolean
C0021430 (UMLS CUI [1])
Persistent asthma Disease length
Item
history of persistent bronchial asthma for at least 6 months
boolean
C3266628 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Adrenal Cortex Hormones by Inhalation Dose Stable | Fluticasone propionate U/day | Equivalent
Item
current treatment with an inhaled corticosteroid (ics) at a stable dose in the dose range of 200-1000 μg fluticasone propionate (fp)/day or equivalent for a minimum of 12 weeks
boolean
C0001617 (UMLS CUI [1,1])
C0205535 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
C0117996 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0205163 (UMLS CUI [3])
Inhalation technique Good
Item
good inhalation technique
boolean
C1998547 (UMLS CUI [1,1])
C0205170 (UMLS CUI [1,2])
Adrenal Cortex Hormones by Inhalation Pretreatment | Asthma control questionnaire Score
Item
under the current ics pre-treatment the acq score ranges between ≥ 0.75 and ≥ 2
boolean
C0001617 (UMLS CUI [1,1])
C0205535 (UMLS CUI [1,2])
C3539076 (UMLS CUI [1,3])
C2919686 (UMLS CUI [2,1])
C0449820 (UMLS CUI [2,2])
Laboratory test result abnormal | Suggestive of Disease Unknown | Requirement Clinical Evaluation Additional
Item
clinically relevant abnormal laboratory values suggesting an unknown disease and requiring further clinical evaluation
boolean
C0438215 (UMLS CUI [1])
C0332299 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C4084924 (UMLS CUI [3,2])
C1524062 (UMLS CUI [3,3])
Comorbidity Severe | Malignant disease | Exception Basal cell carcinoma | Exception Squamous cell carcinoma | Hepatitis C | AIDS
Item
concomitant severe diseases (e.g. malignant diseases during the past 5 years [other than basal or squamous cell carcinoma], hepatitis c, acquired immune deficiency syndrome [aids])
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0442867 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0007137 (UMLS CUI [4,2])
C0019196 (UMLS CUI [5])
C0001175 (UMLS CUI [6])
Medical contraindication Adrenal Cortex Hormones by Inhalation | Tuberculosis, Pulmonary | Inactive tuberculosis of lung | Lower respiratory tract infection fungal | Bacterial lower respiratory infection | Viral lower respiratory infection | Requirement Therapeutic procedure Specific
Item
diseases which are contraindications for the use of ics (e.g. active or inactive pulmonary tuberculosis or relevant fungal, bacterial or viral infections of the lower respiratory tract demanding specific treatment)
boolean
C1301624 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
C0205535 (UMLS CUI [1,3])
C0041327 (UMLS CUI [2])
C0748179 (UMLS CUI [3])
C1691221 (UMLS CUI [4])
C0729520 (UMLS CUI [5])
C0729532 (UMLS CUI [6])
C1514873 (UMLS CUI [7,1])
C0087111 (UMLS CUI [7,2])
C0205369 (UMLS CUI [7,3])
Glucocorticoids, Systemic | Depot Steroids Injectable
Item
use of systemic glucocorticosteroids within 4 weeks (injectable depot steroids 6 weeks) before entry into the baseline period, or more than 3 times during the last 6 months
boolean
C3540777 (UMLS CUI [1])
C0086129 (UMLS CUI [2,1])
C0038317 (UMLS CUI [2,2])
C1272883 (UMLS CUI [2,3])